1008 Recruiting Trials

Clinical Trials
in Kentucky

Browse 1008 recruiting clinical trials currently enrolling participants in Kentucky. Search by condition to find trials you may qualify for, at no cost.

Showing 15 of 1008 recruiting trials in Kentucky

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
PHASE2 Birmingham, Alabama +4 sites · Sarcomatoid Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v8
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
PHASE3 Anchorage, Alaska +4 sites · Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8
Recruiting
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
PHASE3 Anchorage, Alaska +4 sites · Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Recruiting
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
PHASE3 Birmingham, Alabama +4 sites · Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Recruiting
APOLLO: A Randomized Phase II Double-Blind Study of Olaparib Versus Placebo Following Curative Intent Therapy in Patients With Resected Pancreatic Cancer and a Pathogenic BRCA1, BRCA2 or PALB2 Mutation
PHASE2 Anchorage, Alaska +4 sites · Resectable Pancreatic Adenocarcinoma, Pancreatic Acinar Cell Carcinoma
Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
PHASE1 Phoenix, Arizona +4 sites · Recurrent Glioblastoma, IDH-Wildtype, MGMT-Methylated Glioblastoma
Recruiting
Platform of Randomized Adaptive Clinical Trials in Critical Illness
NA Tucson, Arizona +4 sites · Respiratory Insufficiency, Extracorporeal Membrane Oxygenation Complication
Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
PHASE3 Birmingham, Alabama +4 sites · Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Recruiting
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
NA Birmingham, Alabama +4 sites · Acute Kidney Injury
Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
PHASE2 Phoenix, Arizona +4 sites · Muscle Invasive Bladder Urothelial Carcinoma, Stage IV Bladder Urothelial Carcinoma AJCC v7
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
PHASE3 Birmingham, Alabama +4 sites · Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Recruiting
Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
PHASE3 Fayetteville, Arkansas +4 sites · Stage IV Lung Cancer AJCC v8, Stage IIIB Lung Cancer AJCC v8
Recruiting
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
PHASE3 Phoenix, Arizona +4 sites · Metastatic Dedifferentiated Liposarcoma, Stage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8
Recruiting
Testing the Addition of an IDH2 Inhibitor, Enasidenib, to Usual Treatment (Cedazuridine-Decitabine) for Higher-Risk Myelodysplastic Syndrome (MDS) With IDH2 Mutation (A MyeloMATCH Treatment Trial)
PHASE2 Berkeley, California +4 sites · Myelodysplastic Syndrome
Recruiting
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
PHASE2 Los Angeles, California +4 sites · Head and Neck Squamous Cell Carcinoma (HNSCC)
Recruiting
See all 1008 results in Kentucky

Check Your Eligibility

Create a free profile and our AI will match you to trials in Kentucky you may qualify for.

Get Matched — Free
No insurance required
Search by Condition in Kentucky
Diabetes Cancer Breast Cancer Depression Anxiety Alzheimer's Heart Disease Asthma Multiple Sclerosis Obesity Parkinson's Lupus Hypertension COPD Stroke Arthritis Kidney Disease COVID-19
Browse Other States
California Texas New York Florida Illinois Pennsylvania Ohio Georgia North Carolina Michigan New Jersey Washington Arizona Massachusetts Tennessee Colorado Minnesota Maryland Wisconsin Oregon